Home Recalls D-0145-2020
Class II · Moderate risk Terminated Initiated Sep 4, 2019 (7 years ago)
Pantoprazole Sodium Delayed Release Tablets, USP, 40 mg, packaged in 90-count bottle, Rx…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
CGMP Deviation: Presence of dark brown discoloration on edges of tablets.
What was recalled
Pantoprazole Sodium Delayed Release Tablets, USP, 40 mg, packaged in 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd, Roorkee - 247661, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC 59746-284-90
Recalling firm Jubilant Cadista Pharmaceuticals, Inc.
NDC code 59746-284-90
Origin MD, United States
Initiated by Voluntary: Firm initiated
FDA recall number D-0145-2020
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Class II · Moderate risk Ongoing Mar 26, 2026
Reason Discoloration: Firm received five (5) complaints stating that, "Tablets discolored darker than normal and have lighter-colored spots."
Class II · Moderate risk Terminated Sep 5, 2023
Reason Lack of Assurance of Sterility: Powder discoloration due to small crack in some vials.
Class II · Moderate risk Completed Apr 7, 2023
Reason CGMP Deviations; The impacted product and lot number was inadvertently placed into saleable inventory, which does not comply with approved procedures.
Class II · Moderate risk Ongoing Mar 14, 2023
Reason CGMP Deviations: Discoloration
Class II · Moderate risk Terminated Dec 27, 2022
Reason Lack of sterility assurance